Navigating FDA Fast-Track Pathways

How Needle-Free Epinephrine and Nasal Medication Innovations Move Faster In an era where severe allergic reactions and anaphylaxis demand rapid treatment, biopharma companies like Belhaven Biopharma are driving innovation in needle-free medication. The FDA’s 505(b)(2) fast-track pathway allows drug developers…

How to Use Nasdepi®

Managing a severe allergic reaction shouldn’t be complicated. When anaphylaxis strikes, clarity and speed matter most. Nasdepi® is being developed as a needle-free epinephrine option that’s designed for simple, rapid intranasal use, especially helpful for people with needle phobia. In…